跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,910 条关于
“junctional epidermolysis bullosa”
全部
6,910
临床试验
6,673
药物
15
机构
9
资讯
213
去年
Long-term EASE Trial Shows Promise: Birch Triterpenes Demonstrates Sustained Wound Reduction in Epidermolysis Bullosa Patients
去年
FDA Approves Groundbreaking Gene Therapy for Dystrophic Epidermolysis Bullosa
去年
RLF-TD011 Spray Shows Promise in Healing Epidermolysis Bullosa Wounds
去年
FDA Grants Rare Pediatric Disease Designation to Relief Therapeutics' EB Treatment RLF-TD011
上个月
Eloxx Pharmaceuticals Strengthens Balance Sheet with $66 Million Offering, Advances Exaluren Toward Phase 2b in Alport Syndrome
去年
Relief Therapeutics' RLF-TD011 Shows Promise in Epidermolysis Bullosa Trial
去年
Paradigm Therapeutics Secures $12.5M Investment to Advance Novel Epidermolysis Bullosa Treatment
去年
FDA Upgrades Xinnate's TCP-25 Trial for Epidermolysis Bullosa to Registrational Status
去年
INmune Bio's Treatment for Epidermolysis Bullosa Awarded FDA Orphan Designation
9个月前
Xinnate Advances TCP-25 for Epidermolysis Bullosa with FDA IND Approval and First Clinical Publication
第 1 页，共 22 页
上一页
下一页
